Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles. [[{“value”:”Marco Mannes, Wioleta M. Zelek, Leendert A. Trouw”}]]
Complement therapeutics have expanded considerably, but systemic inhibitors remain limited by infection risks, breakthrough events, and loss of physiological functions. Emerging targeted approaches aim for organ-, tissue-, or cell-specific modulation of complement activity, potentially offering greater precision while reducing treatment burden and preserving beneficial complement functions. ABSTRACT The landscape of complement therapeutics has significantly broadened … Read more